Corient Private Wealth’s Vanguard S&P Mid-Cap 400 Growth ETF IVOG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$960K Sell
7,676
-3,816
-33% -$487K ﹤0.01% 1685
2025
Q4
$1.38M Buy
11,492
+5,848
+104% +$702K ﹤0.01% 1718
2025
Q3
$674K Buy
+5,644
New +$662K ﹤0.01% 1634
2025
Q1
Sell
-1,953
Closed -$220K 2367
2024
Q4
$220K Sell
1,953
-441
-18% -$51.8K ﹤0.01% 2065
2024
Q3
$274K Buy
+2,394
New +$266K ﹤0.01% 2051

Other funds holding IVOG

Corient Private Wealth's IVOG Position: Q1 2026 in Review

Corient Private Wealth reduced its Vanguard S&P Mid-Cap 400 Growth ETF (IVOG) stake by 33% in Q1 2026, selling an estimated $487K and leaving 7,676 shares worth $960K. The position accounts for ﹤0.01% of the portfolio, ranked #1685.

Corient Private Wealth first reported a position in IVOG in Q3 2024 and has held it in 5 quarters since. The position peaked at $1.38M in Q4 2025. 178 funds tracked by Wall St. Rank hold IVOG as of Q1 2026.

  • Corient Private Wealth held 7,676 shares of Vanguard S&P Mid-Cap 400 Growth ETF worth $960K as of Q1 2026.
  • Corient Private Wealth sold 3,816 Vanguard S&P Mid-Cap 400 Growth ETF shares in Q1 2026, an estimated $487K.
  • Vanguard S&P Mid-Cap 400 Growth ETF made up ﹤0.01% of Corient Private Wealth's portfolio in Q1 2026, its #1685 holding.
  • Corient Private Wealth first reported a position in Vanguard S&P Mid-Cap 400 Growth ETF in Q3 2024 and has held it in 5 quarters since.
  • Corient Private Wealth's Vanguard S&P Mid-Cap 400 Growth ETF position peaked at $1.38M in Q4 2025.
  • 178 funds tracked by Wall St. Rank held Vanguard S&P Mid-Cap 400 Growth ETF as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.